Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

RPR scientists try a new approach to gpIIb/IIIa antagonists

Sep. 5, 1997

DuPont Merck discloses new anticoagulants

Sep. 4, 1997

Reteplase is superior to alteplase in pulmonary embolism

Sep. 2, 1997

New inhibitors of platelet aggregation from Taiwan

Sep. 2, 1997

Spotlight on fibrinogen antagonists

Sep. 2, 1997

TNK-tPA as effective as tPA, studies show

Aug. 27, 1997

PRISM-PLUS results on tirofiban released

Aug. 27, 1997

Initial PURSUIT trial results presented in Stockholm

Aug. 25, 1997

Lovenox superiority established in ESSENCE trial

Aug. 21, 1997

Fibrinogen antagonists from Yamanouchi

Aug. 20, 1997

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....